Decontamination of human skin exposed to 2,3,7,8-tetrachlorodibenzo-p-Dioxin (TCDD) in vitro.
Human post-mortem skin was exposed in vitro to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at 32 degrees C, under controlled humidity. In one-half of the samples, damage to the surface of the skin was simulated by stripping of the stratum corneum. After incubation with TCDD for 100 min, four different decontamination protocols were performed: (1) the sample was wiped with dry, adsorbent material (cotton balls); (2) a 10-min topical treatment with mineral oil was followed by dry wiping with cotton balls; (3) a 10-min topical treatment with mineral oil was followed by wiping with acetone-soaked cotton balls; and (4) the sample was washed with water and soap. After decontamination, skin samples were incubated (up to 300 min) again at 32 degrees C. One set of both intact and stripped TCDD-exposed skin samples was incubated for 300 min--absent decontamination--and was used as a control. Mineral oil treatment and acetone wipes, or water and soap, were effective in reducing (i.e., about two-fold) the amount of TCDD in the stratum corneum of intact skin. Mineral oil plus dry wipes reduced the amount of TCDD in the stratum corneum by about one-third, whereas dry wiping alone was ineffective. All protocols, however, were similarly effective in reducing the amount of TCDD in the epidermis and upper dermis; TCDD concentrations were decreased locally by factors of up to ten. In the lower dermis, a minimal effect of the decontamination procedures was observed.(ABSTRACT TRUNCATED AT 250 WORDS)
Weber
L W
LW
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City.
Zesch
A
A
Rozman
K
K
D000096:Acetone / Q000627:therapeutic use; D002250:Carbon Radioisotopes; D002985:Clinical Protocols / Q000592:standards*; D003666:Decontamination / Q000379:methods* / Q000592:standards; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008899:Mineral Oil / Q000627:therapeutic use; D000072317:Polychlorinated Dibenzodioxins / Q000737:chemistry*; D012867:Skin / Q000737:chemistry* / Q000293:injuries; D012915:Soaps / Q000627:therapeutic use
D002250:Carbon Radioisotopes; D000072317:Polychlorinated Dibenzodioxins; D012915:Soaps; D000096:Acetone; D008899:Mineral Oil